Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

Complications of Diabetes Mellitus

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Has Big Pharma hijacked the European health research budget?

Lancet (London, England)·2014

Same author

BBC must ensure commentators' tobacco industry links are made public.

Lancet (London, England)·2014

Same author

Ukraine: not only a matter of geopolitics.

Lancet (London, England)·2014

Same author

Ukraine: not only a matter of geopolitics.

Lancet (London, England)·2014

Same author

From public to planetary health: a manifesto.

Lancet (London, England)·2014

Same author

Public-private partnerships with large corporations: setting the ground rules for better health.

Health policy (Amsterdam, Netherlands)·2014

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Diabetes during the Russian transition.

Francesca Perlman¹, Martin McKee

¹ECOHOST, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom.

Diabetes Research and Clinical Practice

|January 29, 2008

Summary

Diabetes awareness and care in Russia were low, particularly in men and rural populations, with significant gaps in diagnosis and treatment. This highlights a potential burden of unrecognised and undertreated diabetes.

Related Experiment Videos

Last Updated: Jul 7, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Area of Science:

Public Health
Epidemiology
Endocrinology

Background:

Post-transition Russia experienced rising mortality rates, including diabetes-related deaths.
Healthcare systems faced significant disruption during this period.

Purpose of the Study:

To investigate trends in diabetes awareness and treatment in Russia from 1994 to 2003.
To identify demographic and socioeconomic factors influencing diabetes diagnosis.

Main Methods:

Analysis of eight rounds (1994-2003) of the Russia Longitudinal Monitoring Survey.
Inclusion of over 7000 respondents aged over 18 per round.
Logistic regression used to analyze determinants of diagnosis in 1994 and 2003.

Main Results:

Diabetes awareness was significantly lower than biochemical prevalence estimates (6% vs. 9%).
Awareness was three times higher in women than men, with wider gender and socioeconomic disparities over time.
Over half of diagnosed individuals received no conventional treatment; insulin use was infrequent.

Conclusions:

Low diabetes awareness and treatment rates suggest a substantial burden of undiagnosed and undertreated diabetes in Russia.
Unexplained gender and socioeconomic variations in awareness persist.
Addressing these gaps is crucial for reducing preventable morbidity and mortality.